Detalhe da pesquisa
1.
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.
Mult Scler
; 30(3): 396-418, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140852
2.
Negotiating prices of drugs for rare diseases.
Bull World Health Organ
; 94(10): 779-781, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843170
3.
The European challenges of funding orphan medicinal products.
Orphanet J Rare Dis
; 13(1): 184, 2018 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396361
4.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol
; 8: 497, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878667
5.
Pharmaceutical regulation in 15 European countries review.
Health Syst Transit
; 18(5): 1-122, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27929376
6.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
7.
Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries.
Orphanet J Rare Dis
; 8: 198, 2013 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24365263